openPR Logo
Press release

Anti-Inflammatory Peptides Market to Develop Rapidly by 2015 – 2023

04-17-2018 08:49 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Anti-Inflammatory Peptides Market to Develop Rapidly by 2015

Anti Inflammatory Peptides Market: Overview

Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal’s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases.

Download PDF Brochure of Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4335

High prevalence of diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and autoimmune diseases is likely to play a key role in driving the market growth for anti-inflammatory peptides. According to the World Psoriasis Day consortium, worldwide nearly 125 million people are affected with psoriasis, approximately 2% to 3% of the global population. The World Health Organization (WHO) predicts the median multiple sclerosis prevalence approximately 30 per 100,000 individuals. Crohn’s disease (CD) and ulcerative colitis (UC) are two major inflammatory bowel diseases. Crohn’s disease has been observed to be more prevalent in urban areas than rural. Statistics released by the World Health Organization (WHO) indicates that the CD incidence rate in Asian and South American countries is less than 1 per 10,000 people, 1–3 per 100,000 in southern Europe, South Africa, 16 per 100,000 in New Zealand and Australia and 7 per 100,000 in the U.S. Such high prevalence and incidence rate of aforementioned diseases indicates promising market for anti-inflammatory peptides.

There are many companies that are striving to develop anti-Inflammatory peptides. One of them is San Francisco Bay Area based start-up named Rogne Biosciences that plans to develop world’s first topical anti-Inflammatory peptide product, derived from naturally occurring body protein to treat patients suffering from psoriasis. Rogne Biosciences has obtained a licensing agreement from Isis Innovation, the commercialization company of University of Oxford, to develop anti-inflammatory peptides. In February 2013, Phylogica, a leading peptide drug discovery company, and Bio-Link Australia signed an agreement to commercialize anti-inflammatory Phylomer peptides for pharmaceutical use. This commercialization effort of both companies will be funded by a grant of USD 20,000 from the Western Australian government under the Innovation Vouchers Program (IVP). A research is going on to study the cationic antimicrobial peptides effectiveness against clinically relevant microorganisms such as propionibacterium acnes. The study demonstrates that in addition to the antimicrobial activity, cationic antimicrobial peptides also exhibit anti-inflammatory effect.

Request to View TOC of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=4335

Globally, North America, Europe, Asia-Pacific and Rest of the World (RoW) are the four major regions for which anti-inflammatory peptides market has been analyzed. In North America, U.S. and Canada are the major countries. Well established healthcare infrastructure and insurance landscape of these two countries have led North America dominating the anti-inflammatory peptides market. According to the National Psoriasis Foundation, approximately 7.5 million people (2.2% of the population) in the U.S. are living with psoriasis. As per the National Multiple Sclerosis Society, 400,000 individuals estimated to have multiple sclerosis in the U.S. The high prevalence of psoriasis and multiple sclerosis is also responsible for North America’s leading position in the global anti-inflammatory peptides market. In the European region, the EU-5 countries (Germany, France, U.K., Spain and Italy) represent the most potential markets. However, during the forecast period from 2014 to 2020, Eastern European region are expected to witness high growth rate than western region. The growing economy of countries such as India and China, and continuously improving healthcare scenario of Asia-Pacific region are the key factors driving the market growth in the region.

Some of the major players contributing to the global anti-inflammatory peptides market include Abbvie, Digna Biotech, Araim Pharmaceuticals, Inc., F4 Pharma, Merck Serono, Rogne Bioscience, Novartis AG and Mylan Pharmaceuticals.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4335

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’Anti Inflammatory Peptides Market: Overview

Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal’s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases.

Download PDF Brochure of Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4335

High prevalence of diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and autoimmune diseases is likely to play a key role in driving the market growth for anti-inflammatory peptides. According to the World Psoriasis Day consortium, worldwide nearly 125 million people are affected with psoriasis, approximately 2% to 3% of the global population. The World Health Organization (WHO) predicts the median multiple sclerosis prevalence approximately 30 per 100,000 individuals. Crohn’s disease (CD) and ulcerative colitis (UC) are two major inflammatory bowel diseases. Crohn’s disease has been observed to be more prevalent in urban areas than rural. Statistics released by the World Health Organization (WHO) indicates that the CD incidence rate in Asian and South American countries is less than 1 per 10,000 people, 1–3 per 100,000 in southern Europe, South Africa, 16 per 100,000 in New Zealand and Australia and 7 per 100,000 in the U.S. Such high prevalence and incidence rate of aforementioned diseases indicates promising market for anti-inflammatory peptides.

There are many companies that are striving to develop anti-Inflammatory peptides. One of them is San Francisco Bay Area based start-up named Rogne Biosciences that plans to develop world’s first topical anti-Inflammatory peptide product, derived from naturally occurring body protein to treat patients suffering from psoriasis. Rogne Biosciences has obtained a licensing agreement from Isis Innovation, the commercialization company of University of Oxford, to develop anti-inflammatory peptides. In February 2013, Phylogica, a leading peptide drug discovery company, and Bio-Link Australia signed an agreement to commercialize anti-inflammatory Phylomer peptides for pharmaceutical use. This commercialization effort of both companies will be funded by a grant of USD 20,000 from the Western Australian government under the Innovation Vouchers Program (IVP). A research is going on to study the cationic antimicrobial peptides effectiveness against clinically relevant microorganisms such as propionibacterium acnes. The study demonstrates that in addition to the antimicrobial activity, cationic antimicrobial peptides also exhibit anti-inflammatory effect.

Request to View TOC of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=4335

Globally, North America, Europe, Asia-Pacific and Rest of the World (RoW) are the four major regions for which anti-inflammatory peptides market has been analyzed. In North America, U.S. and Canada are the major countries. Well established healthcare infrastructure and insurance landscape of these two countries have led North America dominating the anti-inflammatory peptides market. According to the National Psoriasis Foundation, approximately 7.5 million people (2.2% of the population) in the U.S. are living with psoriasis. As per the National Multiple Sclerosis Society, 400,000 individuals estimated to have multiple sclerosis in the U.S. The high prevalence of psoriasis and multiple sclerosis is also responsible for North America’s leading position in the global anti-inflammatory peptides market. In the European region, the EU-5 countries (Germany, France, U.K., Spain and Italy) represent the most potential markets. However, during the forecast period from 2014 to 2020, Eastern European region are expected to witness high growth rate than western region. The growing economy of countries such as India and China, and continuously improving healthcare scenario of Asia-Pacific region are the key factors driving the market growth in the region.

Some of the major players contributing to the global anti-inflammatory peptides market include Abbvie, Digna Biotech, Araim Pharmaceuticals, Inc., F4 Pharma, Merck Serono, Rogne Bioscience, Novartis AG and Mylan Pharmaceuticals.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4335s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Inflammatory Peptides Market to Develop Rapidly by 2015 – 2023 here

News-ID: 1020388 • Views: 306

More Releases from Transparency Market Research

Cast Iron Cookware Market To Witness an Outstanding Growth By 2025
The vendor landscape of the global cast iron cookware market is primarily characterized by a high level of fragmentation owing to the presence of several multinationals as well as a large number of unorganized domestic players in key regional markets. Increasing competition among key players is the main challenge for cast iron cookware manufacturers, which is likely to lead to a decrease in profit margins. As competition intensifies in this
Biometric Point-of-Sale Terminals Market Regulations and Competitive Landscape O …
Biometrics technology is used for identification and authentication of people with the help of their biological and behavioral characteristics. An employee is asked for his user ID as soon as he logs into the retail PoS system. However, without typing in his password, he can simply scan his finger on the biometric fingerprint reader. Every time an employee tries to access a password-protected area, he is required to scan his
Solid State Connector Market To Expand Substantially Owing To Technological Inno …
The demand for solid state connector technologies has got a proportionate boost from rising adoption of solid-state lighting (SLL) technologies. In various parts of the globe, the market for technologies light-emitting diode (LED) or organic light-emitting diode (OLED) has gathered immense pace in recent decades. Choosing the right solid state connector has been one of the key determinants of designing high performing SSL luminaries. The market is witnessing an array
Walnut Butter Market - Valuable Growth And Future Scenario Forecast 2017 – 202 …
Global Walnut Butter Market Introduction: Walnut Butter is a vegetarian source of omega-3 fatty acids in addition to nutrition such as fiber, protein vitamins, and minerals. Global walnut butter market is expected to gain significant basis points in global butter market over the forecast period, owing to the presence of omega-3 fatty acids which act effectively in lower the risk of depression, high blood pressure, stroke, cancer, diabetes, and other heart

All 5 Releases


More Releases for Anti

Anti-microbial/Anti-fungal Tests Market
Microbial and fungal infections are a major cause of death globally and can even cause potential epidemics, creating a huge economic burden on countries, especially developing ones. To nip the spread of such infections in the bud, prevention is a far better solution than cure - accomplished by isolating infected cases and carrying out primary screening tests. Future Market Insights in its report titled ‘Anti-microbial/Anti-fungal Tests Market: Global Industry Analysis
Anti-venom Market, by Anti-venom Type (Polyvalent, Monovalent),
Anti-venom is a medication majorly used to treat snake bites and it can also be used to treat bites from scorpions, spiders or other reptiles. It is made by fractionating the blood of the donor (horse or sheep), which is hyper immunized with snake venom. These products are available in either lyophilized or liquid forms. Anti-venom is the only effective therapy against snake bites and apart from lifesaving, they
Anti-Snoring Treatment Market
Snoring is the vibration of respiratory structures which results in sound while sleeping. It is a sleeping disorder caused due to monotonous narrowing and collapsing of the upper airway. Snoring have various adverse effects on health include coronary artery disease, systemic hypertension, atrial fibrillation, and stroke. Snoring is one of the factors of sleep deprivation, which may be further caused due to throat weakness, mis-positioned jaw, obesity, and obstruction in
Global Anti-Foam Market
Anti-foam market: Drivers The applications of anti-foam agents are extensive and varied. The demand is rising with time. The antifoam market will grow and shine in the coming few years. Staggering expansion of the pharmaceuticals industry, packaged food industry, textile industry will drive the overall development of the antifoam markets spread across the globe. To compliment this soaring demand, several new players are foraying in the antifoam production market. Funds are
Global Anti-Fatigue Insoles Market
It is important that following factors are considered in the case of wearing anti-fatigue insoles. Such type of insoles should be made up of elastic material. Insoles should properly fit the shoes of the wearer. Last but not the least, it should be remembered that insoles causes increase in the tightness of the shoes, leading to various adverse effects. In addition, various studies have suggested that use of anti-fatigue insoles
Anti-Reflective Coatings Market
An anti-reflective coating is an optical coating that is applied on any lens surface or optical element to reduce the reflection. In a typical imaging system, this improves efficiency as much less light is lost. While the primary benefit is the reduced reflection itself, an anti-reflective coating on something like a pair of spectacles helps make the wearer’s eyes more visible, aiding eye contact. It also helps reduce the glint